These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9366909)
1. Activation and detoxification of dinitropyrenes by cytosol and microsomes from Aroclor-pretreated rats in the Ames and umu assays. Shane BS; Winston GW Environ Mol Mutagen; 1997; 30(3):303-11. PubMed ID: 9366909 [TBL] [Abstract][Full Text] [Related]
2. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment. Traynor CA; Shane BS; Hajos AK; Winston GW Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800 [TBL] [Abstract][Full Text] [Related]
3. Modulation of the mutagenicity of three dinitropyrene isomers in vitro by rat-liver S9, cytosolic, and microsomal fractions following chronic ethanol ingestion. Winston GW; Traynor CA; Shane BS; Hajos AK Mutat Res; 1992 Jun; 279(4):289-98. PubMed ID: 1377785 [TBL] [Abstract][Full Text] [Related]
4. Activation and detoxification of 1,8-dinitropyrene by mammalian hepatic fractions in the Salmonella mutagenicity assay. Shah AB; Combes RD; Rowland IR Mutagenesis; 1990 Jan; 5(1):45-9. PubMed ID: 2184311 [TBL] [Abstract][Full Text] [Related]
5. Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test. Ayrton AD; Neville S; Ioannides C Mutat Res; 1992 Jan; 265(1):1-8. PubMed ID: 1370238 [TBL] [Abstract][Full Text] [Related]
6. Interaction with microsomal lipid as a major factor responsible for S9-mediated inhibition of 1,8-dinitropyrene mutagenicity. Shah AB; Combes RD; Rowland IR Mutat Res; 1991 Jul; 249(1):93-104. PubMed ID: 2067546 [TBL] [Abstract][Full Text] [Related]
7. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay. Milling DM; Maddock MB Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163 [TBL] [Abstract][Full Text] [Related]
8. Effect of tryptamine on the mutagenic activity of 2-amino-3-methylimidazo(4,5-f) quinoline (IQ) and related azaarenes in the Ames test. Abu-Shakra A; Ioannides C; Walker R Mutagenesis; 1987 Jan; 2(1):51-6. PubMed ID: 3331694 [TBL] [Abstract][Full Text] [Related]
9. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay. Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308 [TBL] [Abstract][Full Text] [Related]
10. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay. Amacher DE; Turner GN Mutat Res; 1980 Dec; 74(6):485-501. PubMed ID: 7464853 [TBL] [Abstract][Full Text] [Related]
11. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences. Abu-Shakra A; Ioannides C; Walker R Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675 [TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of organic extracts from diesel, coke oven, roofing tar, and cigarette smoke emissions in the Ames assay. Williams K; Lewtas J Environ Mutagen; 1985; 7(4):489-500. PubMed ID: 2414095 [TBL] [Abstract][Full Text] [Related]
14. Is a liver comparable to a liver? A comparison of different rat-derived S9-fractions with a biotechnological animal-free alternative in the Ames fluctuation assay. Brendt J; Crawford SE; Velki M; Xiao H; Thalmann B; Hollert H; Schiwy A Sci Total Environ; 2021 Mar; 759():143522. PubMed ID: 33246726 [TBL] [Abstract][Full Text] [Related]
15. A cytosolic oxygenase activity involved in the bioactivation of 2-aminofluorene. Leist M; Ayrton AD; Ioannides C Toxicology; 1992; 71(1-2):7-20. PubMed ID: 1729770 [TBL] [Abstract][Full Text] [Related]
16. Dinitropyrene nitroreductase activity of purified NAD(P)H-quinone oxidoreductase: role in rat liver cytosol and induction by Aroclor-1254 pretreatment. Hajos AK; Winston GW Carcinogenesis; 1991 Apr; 12(4):697-702. PubMed ID: 1901525 [TBL] [Abstract][Full Text] [Related]
17. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests. Gatehouse D; Wedd DJ Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032 [TBL] [Abstract][Full Text] [Related]
18. Effect of liver enzymes on the mutagenicity of nitroheterocyclic compounds: activation of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)- 1,2-benzisoxazole and deactivation of nitrofurans and nitroimidazoles in the Ames test. Skeggs HR; Berglund RM; VandenHeuvel WJ; Mrozik H; Wislocki PG; Wolf FJ Mutat Res; 1984 Apr; 136(1):1-8. PubMed ID: 6371510 [TBL] [Abstract][Full Text] [Related]
19. Increased mutagenicity of chloroethylnitrosoureas in the presence of a rat liver S9 microsome mixture. Suling WJ; Rice LS; Shannon WM J Natl Cancer Inst; 1983 Apr; 70(4):767-9. PubMed ID: 6220173 [TBL] [Abstract][Full Text] [Related]
20. Optimization of metabolic activation for four mutagens in a bacterial, fungal and two mammalian cell mutagenesis assays. Rees RW; Brice AJ; Carlton JB; Gilbert PJ; Mitchell ID Mutagenesis; 1989 Sep; 4(5):335-42. PubMed ID: 2687626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]